DOI QR코드

DOI QR Code

Prolongation of the effect of a single dose of rocuronium in a patient with postpolio syndrome under desflurane anesthesia: a case report

  • Kimura, Yukifumi (Department of Dental Anesthesiology, Faculty of Dental Medicine and Graduate School of Dental Medicine, Hokkaido University) ;
  • Nitta, Yukie (Department of Dental Anesthesiology, Faculty of Dental Medicine and Graduate School of Dental Medicine, Hokkaido University) ;
  • Shibuya, Makiko (Department of Dental Anesthesiology, Faculty of Dental Medicine and Graduate School of Dental Medicine, Hokkaido University) ;
  • Fujisawa, Toshiaki (Department of Dental Anesthesiology, Faculty of Dental Medicine and Graduate School of Dental Medicine, Hokkaido University)
  • Received : 2022.02.10
  • Accepted : 2022.04.05
  • Published : 2022.06.01

Abstract

Postpolio syndrome (PPS) is widely known to manifest as muscle weakness in patients affected by poliomyelitis in early childhood. This is caused by the long-term overwork of motor nerves regenerated from surviving nerve cells. We report a characteristic delay in recovery from muscle relaxation after administering rocuronium to a patient with PPS under general anesthesia with desflurane. A 59-year-old woman was scheduled to undergo surgical debridement for jaw osteonecrosis. She had a history of poliomyelitis at the age of 2 years, and was diagnosed with PPS at the age of 51 years. General anesthesia was induced with 80 mg propofol, 50 ㎍ fentanyl, and 30 mg (0.69 mg/kg) rocuronium, and maintained with desflurane and remifentanil. The durations of train-of-four (TOF) count 0 and 1 were 96 and 37 min, respectively. Five minutes after discontinuing desflurane, the TOF count was 4. Three minutes after administering 200 mg sugammadex, the TOF ratio was 0.83, and the tracheal tube was subsequently removed. In summary, the effect of a single dose of rocuronium on twitch in TOF monitoring was significantly prolonged in a patient with PPS, which may have been exacerbated by desflurane.

Keywords

Acknowledgement

We would like to thank Editage (www.editage.com) for English language editing.

References

  1. Halstead LS, Rossi CD. Post-polio syndrome: clinical experience with 132 consecutive outpatients. Birth Defects Orig Artic Ser 1987; 23: 13-26.
  2. Gawne AC, Halstead LS. Post-polio syndrome: pathophysiology and clinical management. Crit Rev Phys Rehabil Med 1995; 7: 147-88. https://doi.org/10.1615/CritRevPhysRehabilMed.v7.i2.40
  3. Nam KY, Lee S, Yang EJ, Kim K, Jung SH, Jang SN, et al. Falls in Korean polio survivors: incidence, consequences, and risk factors. J Korean Med Sci 2016; 31: 301-9. https://doi.org/10.3346/jkms.2016.31.2.301
  4. Gonzalez H, Olsson T, Borg K. Management of postpolio syndrome. Lancet Neurol 2010; 9: 634-42. https://doi.org/10.1016/S1474-4422(10)70095-8
  5. Schwartz A, Bosch LM. Anesthetic implications of postpolio syndrome: new concerns for an old disease. AANA J 2012; 80: 356-61.
  6. Lambert DA, Giannouli E, Schmidt BJ. Postpolio syndrome and anesthesia. Anesthesiology 2005; 103: 638-44. https://doi.org/10.1097/00000542-200509000-00029
  7. Magi E, Recine C, Klockenbusch B, Cascianini EA. A postoperative respiratory arrest in a post poliomyelitis patient. Anaesthesia 2003; 58: 98-9.
  8. Janda A, Urschutz L. Postoperative respiratory insufficiency in patients after poliomyelitis. Anaesthesist 1979; 28: 249.
  9. Kim KS, Yeon JT, Lee HJ. Time course of neuromuscular effects of rocuronium during desflurane anesthesia in patients with or without renal failure. Korean J Anesthesiol 2009; 57: 566-71. https://doi.org/10.4097/kjae.2009.57.5.566
  10. Gyermek L. Increased potency of nondepolarizing relaxants after poliomyelitis. J Clin Pharmacol 1990; 30: 170-3. https://doi.org/10.1002/j.1552-4604.1990.tb03458.x
  11. Caldwell JE, Laster MJ, Magorian T, Heier T, Yasuda N, Lynam DP, et al. The neuromuscular effects of desflurane, alone and combined with pancuronium or succinylcholine in humans. Anesthesiology 1991; 74: 412-8. https://doi.org/10.1097/00000542-199103000-00004
  12. Wulf H, Ledowski T, Linstedt U, Proppe D, Sitzlack D. Neuromuscular blocking effects of rocuronium during desflurane, isoflurane, and sevoflurane anaesthesia. Can J Anaesth 1998; 45: 526-32. https://doi.org/10.1007/BF03012702
  13. Bock M, Klippel K, Nitsche B, Bach A, Martin E, Motsch J. Rocuronium potency and recovery characteristics during steady-state desflurane, sevoflurane, isoflurane or propofol anaesthesia. Br J Anaesth 2000; 84: 43-7. https://doi.org/10.1093/oxfordjournals.bja.a013380
  14. Tanabe K, Takahashi H, Iida H. Safe use of rocuronium for a post-polio syndrome patient. J Anesth 2015; 29: 316. https://doi.org/10.1007/s00540-014-1906-7
  15. Sonobe S, Imashuku Y, Inamori M, Yabuta K, Hashimura T, Kura M, et al. General anesthesia for a patient with post-polio syndrome. Masui 2013; 62: 962-4.